[go: up one dir, main page]

ZA914349B - Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof - Google Patents

Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof

Info

Publication number
ZA914349B
ZA914349B ZA914349A ZA914349A ZA914349B ZA 914349 B ZA914349 B ZA 914349B ZA 914349 A ZA914349 A ZA 914349A ZA 914349 A ZA914349 A ZA 914349A ZA 914349 B ZA914349 B ZA 914349B
Authority
ZA
South Africa
Prior art keywords
sulfate
preparation
ws7622a
mono
ws7622a mono
Prior art date
Application number
ZA914349A
Other languages
English (en)
Inventor
Shigehiro Takase
Takase Shigehiro
Hiroshi Hatanaka
Hatanaka Hiroshi
Masami Ezaki
Ezaki Masami
Eisaku Tsujii
Tsujii Eisaku
Masanori Okamoto
Okamoto Masanori
Nobuharu Shigematsu
Shigematsu Nobuharu
Masakuni Okuhara
Okuhara Masakuni
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of ZA914349B publication Critical patent/ZA914349B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2/00Peptides of undefined number of amino acids; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K4/00Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/04Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
ZA914349A 1990-06-29 1991-06-06 Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof ZA914349B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909014546A GB9014546D0 (en) 1990-06-29 1990-06-29 Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof

Publications (1)

Publication Number Publication Date
ZA914349B true ZA914349B (en) 1992-03-25

Family

ID=10678456

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA914349A ZA914349B (en) 1990-06-29 1991-06-06 Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof

Country Status (22)

Country Link
US (2) US5292510A (xx)
EP (1) EP0465895B1 (xx)
JP (1) JP2663763B2 (xx)
KR (1) KR100198693B1 (xx)
CN (1) CN1073115C (xx)
AT (1) ATE138074T1 (xx)
AU (1) AU640241B2 (xx)
CA (1) CA2045761C (xx)
DE (1) DE69119488T2 (xx)
DK (1) DK0465895T3 (xx)
ES (1) ES2087178T3 (xx)
FI (1) FI106554B (xx)
GB (1) GB9014546D0 (xx)
GR (1) GR3020184T3 (xx)
HU (1) HU213398B (xx)
IE (1) IE75702B1 (xx)
IL (1) IL98394A (xx)
NO (1) NO301643B1 (xx)
PH (1) PH31239A (xx)
PT (1) PT98134B (xx)
RU (1) RU2087482C1 (xx)
ZA (1) ZA914349B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE161016T1 (de) * 1991-06-18 1997-12-15 Fujisawa Pharmaceutical Co Ws7622a enthaltende prophylaktische/therapeutische zusammensetzung zur vorbeugung und behandlung von verstreuter, intravaskulärer koagulation, chronischer, infektiöser atemwegskrankheiten oder chronischer bronchitis
US5384119A (en) * 1993-08-12 1995-01-24 Merrell Dow Pharmaceuticals Inc. Method of preventing neutrophil mediated connective tissue damage
JP2002161051A (ja) * 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
EP1057491B1 (en) * 1998-02-24 2013-06-19 Astellas Pharma Inc. Preventives/remedies for skin aging
CN109406709B (zh) * 2018-12-27 2020-11-10 福建省中医药研究院(福建省青草药开发服务中心) 一种太子参药材中氨基酸类成分的薄层鉴别方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27266A (en) * 1989-03-14 1993-05-04 Fujisawa Pharmaceutical Co WS7622, A,B,C and D substances and pharmaceutical composition containing same

Also Published As

Publication number Publication date
JPH04279600A (ja) 1992-10-05
FI912914L (fi) 1991-12-30
CA2045761C (en) 1999-09-21
FI912914A0 (fi) 1991-06-17
DE69119488T2 (de) 1996-10-02
NO912561D0 (no) 1991-06-28
JP2663763B2 (ja) 1997-10-15
HU213398B (en) 1997-06-30
IL98394A (en) 1995-03-30
PT98134B (pt) 1998-12-31
US5364624A (en) 1994-11-15
CA2045761A1 (en) 1991-12-30
HU912198D0 (en) 1991-12-30
GR3020184T3 (en) 1996-09-30
IL98394A0 (en) 1992-07-15
US5292510A (en) 1994-03-08
CN1057655A (zh) 1992-01-08
EP0465895B1 (en) 1996-05-15
KR920000920A (ko) 1992-01-29
EP0465895A1 (en) 1992-01-15
IE75702B1 (en) 1997-09-10
FI106554B (fi) 2001-02-28
IE912047A1 (en) 1992-01-01
RU2087482C1 (ru) 1997-08-20
ATE138074T1 (de) 1996-06-15
HUT58351A (en) 1992-02-28
AU7939491A (en) 1992-01-09
NO912561L (no) 1991-12-30
KR100198693B1 (ko) 1999-06-15
ES2087178T3 (es) 1996-07-16
DE69119488D1 (de) 1996-06-20
GB9014546D0 (en) 1990-08-22
AU640241B2 (en) 1993-08-19
PH31239A (en) 1998-06-18
CN1073115C (zh) 2001-10-17
NO301643B1 (no) 1997-11-24
DK0465895T3 (da) 1996-06-03
PT98134A (pt) 1992-06-30

Similar Documents

Publication Publication Date Title
IL104437A0 (en) 4"-deoxyerythromycin derivatives
GR3023353T3 (en) Cyclic peptide antagonists of Substance P and Substance K
TW252979B (xx)
GB9014546D0 (en) Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof
HUT63462A (en) Process for producing new glycopeptides and pharmaceutical compositions comprising same as active ingredient
IL93548A0 (en) Ws7622a,b,c and d substances,derivatives thereof,processes for the preparation thereof and pharmaceutical compositions containing the same
HUT57227A (en) 2'-dezamino-4'-desoxy-4'-amino-8-fluoro-anthracycline derivatives, process for producing them as well as pharmaceutical preparatives containing said compounds as active substance
IL86169A (en) Substituted quinoxalyl-imidazolidine-2,4-diones,processes for their preparation and pharmaceutical compositions containing them
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use
HUT49886A (en) Process for producing new beta-lactam antibiotics and pharmaceutical compositions comprising same
IE901180L (en) Polar cephalosporin derivatives and a process for the¹preparation thereof
ZA828237B (en) A vasodilator compound,process for the preparation thereof and pharmaceutical compositions therefrom
HUT53654A (en) Process for producing cefemcarboxylic acid compounds and pharmaceutical compositions comprising such compounds
IT1254565B (it) Forma cristallina dell'endo-2,3-diidro-n-(8 metil-8-azabiciclo-(3.2.1) ott-3-il)-2-oxo-1h-benzimidazolo-1-carbossamide cloridrato